期刊文献+
共找到10篇文章
< 1 >
每页显示 20 50 100
Leuprolide acetate induces structural and functional recovery of injured spinal cord in rats 被引量:2
1
作者 Carmen Díaz Galindo Beatriz Gómez-González +4 位作者 Eva Salinas Denisse Calderón-Vallejo Irma Hernández-Jasso Eduardo Bautista J Luis Quintanar 《Neural Regeneration Research》 SCIE CAS CSCD 2015年第11期1819-1824,共6页
Gonadotropin-releasing hormone(Gn RH) and its synthetic analog leuprolide acetate, a Gn RH agonist, have neurotrophic properties. This study was designed to determine whether administration of leuprolide acetate can... Gonadotropin-releasing hormone(Gn RH) and its synthetic analog leuprolide acetate, a Gn RH agonist, have neurotrophic properties. This study was designed to determine whether administration of leuprolide acetate can improve locomotor behavior, gait, micturition reflex, spinal cord morphology and the amount of microglia in the lesion epicenter after spinal cord injury in rats. Rats with spinal cord compression injury were administered leuprolide acetate or saline solution for 5 weeks. At the 5th week, leuprolide acetate-treated rats showed locomotor activity recovery by 38%, had improvement in kinematic gait and exhibited voiding reflex recovery by 60%, as compared with the 1st week. By contrast, saline solution-treated rats showed locomotor activity recovery only by 7%, but voiding reflex did not recover. More importantly, leuprolide acetate treatment reduced microglial immunological reaction and induced a trend towards greater area of white and gray matter in the spinal cord. Therefore, leuprolide acetate has great potential to repair spinal cord injury. 展开更多
关键词 nerve regeneration spinal cord injury leuprolide acetate gonadotropin-releasing hormone neurotrophic factor MICROGLIA micturition reflex GAIT INFLAMMATION neural regeneration
下载PDF
Clinical Efficacy and Safety of Laparoscopic Postoperative Leuprolide in Treatment of Endometriotic cysts
2
作者 Yu Bin Juan Juan Su Nita 《Proceedings of Anticancer Research》 2018年第2期1-3,共3页
Purpose To investigate the clinical effect of the use of leuprolide after laparoscopic surgery in patients with endometriosis.Method:Select 220 patients with endometriosis treated in our hospital from January 2015 to ... Purpose To investigate the clinical effect of the use of leuprolide after laparoscopic surgery in patients with endometriosis.Method:Select 220 patients with endometriosis treated in our hospital from January 2015 to June 2016,and randomly divided them into simple group and treatment group,with 110 cases in each group.The simple group did not receive any treatment after laparoscopic surgery.The treatment group received leuprolide after surgery.Compare the treatment effect and safety of the two groups of patients.Results The treatment efficiency of the treatment group was significantly better than that of the simple group,P<0.05;and the relapse rate of the treatment group was low,P<0.05.Conclusion The use effect of leuprolide in the treatment of endometriosis patients after laparoscopic surgery is better,with low relapse rate and high safety,and is worthy of clinical promotion. 展开更多
关键词 LAPAROSCOPY leuprolide ENDOMETRIOSIS
下载PDF
Sclerotherapy with Leuprolide and Cefoperazone Sulbactam in the Management of Ovarian Endometriomas under Ultrasound Guidance: A Novel Approach
3
作者 Yazhini Selvaraj 《Advances in Sexual Medicine》 2022年第1期34-46,共13页
<span style="font-family:Verdana;">Endometriosis is an estrogen dependent gynecological disorder, which can occur throughout the reproductive age of women, causing chronic pelvic pain, substantial morb... <span style="font-family:Verdana;">Endometriosis is an estrogen dependent gynecological disorder, which can occur throughout the reproductive age of women, causing chronic pelvic pain, substantial morbidity, and impaired fertility. It is clinically defined as the presence of ectopic endometrium resulting in sustained inflammatory reaction. In India</span><span style="font-family:Verdana;">,</span><span style="font-family:Verdana;"> about 29,000,000 women suffer from endometriosis. Severe pelvic pain and recurrent endometriomas were observed even after surgery. We have conducted aspirations totally in 110 patients in which most of the patients were suffering from Stage III & Stage IV of endometriosis except for 7 patients for whom we have done as primary therapy for endometriomas. Among 110 </span><span style="font-family:Verdana;">patients</span><span style="font-family:;" "=""><span style="font-family:Verdana;">, 4 patients didn’t turn up for follow up after first aspiration. This pilot study conducted with 110 patients in Ponni Hospital and Fertility Research Centre, Madurai aimed to evaluate pregnancy outcome in 51 infertile patients, and to alleviate pelvic pain, to restore a healthy sexual life and to reduce the recurrence rate of Ovarian Endometriomas (OE) in 59 patients, who did not seek fertility, After using the newer sclerosing agent Leuprolide with Cefoperazone Sulbactam (LCS) under ultrasound guidance. This prospective pilot study resulted in a highly significant achievement in pregnancy where 41 patients conceived out of 51 patients (80.39%) only 6 are in ongoing treatment. Those who didn’t seek fertility were 59 of which 43 have </span><span style="font-family:Verdana;">completed family 1</span></span><span style="font-family:Verdana;">3</span><span style="font-family:Verdana;"> have one child</span><span style="font-family:Verdana;"> and 3 unmarried girls</span><span style="font-family:Verdana;">. 96.61% were relieved of pain and recurrence and restored healthy sexual life, 2 are in ongoing treatment. We have not encountered any adverse effects during this</span><span style="font-family:Verdana;"> treatment.</span> 展开更多
关键词 Ovarian Endometriomas (OE) Infertility (IF) Sclerosing Agent (SA) leuprolide with Cefoperazone Sulbactam (LCS) In Vitro Fertilization (IVF)
下载PDF
Leuprolide用于AD的Ⅲ期研究
4
作者 金伟秋(摘) 《国外药讯》 2006年第5期21-21,共1页
Durect公司与Voyager制药公司已开始对阿尔茨海默病(AD)用其缓释的leuprolide植入物Memryte(Ⅰ)的确定剂量Ⅲ期研究。
关键词 leuprolide Ⅲ期 leuprolide AD 阿尔茨海默病 制药公司 植入物
下载PDF
leuprolide植入剂在日本提出申请
5
作者 黄敏燕 《国外药讯》 2005年第7期31-31,共1页
Sosei公司已经向日本递交了其领先产品leuprolide acetate植入剂SOT-375(Ⅰ)治疗前列腺癌的申请。这种3.75mg的产品置于一可生物降解的多聚体内通过皮下给药,这种聚合物能够固化并在30天时间内逐渐释放药物。Sosei公司最初是从QLT(原... Sosei公司已经向日本递交了其领先产品leuprolide acetate植入剂SOT-375(Ⅰ)治疗前列腺癌的申请。这种3.75mg的产品置于一可生物降解的多聚体内通过皮下给药,这种聚合物能够固化并在30天时间内逐渐释放药物。Sosei公司最初是从QLT(原来的Atrix公司)获得在日本的授权,在美国(通过Sanofi—Ayentis公司)和其他国家以商品名Eligard上市该产品。申请批准后,已在泌尿学领域占据一席之地的日本Organon公司(Akzo Nobel公司的一部分)将与Sosei公司合作在日本共同推销(Ⅰ)。武田公司的leuplin(leuprolide acetate,醋酸亮丙瑞林)目前在日本是领先的LHRH激动剂,每年的销售额大约有650亿日元(6.21亿美元)。 展开更多
关键词 leuprolide 植入剂 日本 ACETATE Organon公司 Eligard LHRH激动剂 醋酸亮丙瑞林 可生物降解 前列腺癌 皮下给药 产品 聚合物 商品名 泌尿学 销售额
下载PDF
Preparation and evaluation of a phospholipid-based injectable gel for the long term delivery of leuprolide acetaterrh 被引量:6
6
作者 Danhong Long Tao Gong +2 位作者 Zhirong Zhang Rui Ding Yao Fu 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2016年第4期329-335,共7页
A phospholipid-based injectable gel was developed for the sustained delivery of leuprolide acetate(LA). The gel system was prepared using biocompatible materials(SPME), including soya phosphatidyl choline(SPC), medium... A phospholipid-based injectable gel was developed for the sustained delivery of leuprolide acetate(LA). The gel system was prepared using biocompatible materials(SPME), including soya phosphatidyl choline(SPC), medium chain triglyceride(MCT) and ethanol. The system displayed a sol state with low viscosity in vitro and underwent in situ gelation in vivo after subcutaneous injection. An in vitro release study was performed using a dialysis setup with different release media containing different percentages of ethanol. The stability of LA in the SPME system was investigated under different temperatures and in the presence of various antioxidants. In vivo studies in male rats were performed to elucidate the pharmacokinetic profiles and pharmacodynamic efficacy. A sustained release of LA for 28 days was observed without obvious initial burst in vivo. The pharmacodynamic study showed that once-amonth injection of LA-loaded SPME(SPME-LA) led to comparable suppression effects on the serum testosterone level as observed in LA solution except for the onset time. These findings demonstrate excellent potential for this novel SPME system as a sustained release delivery system for LA. 展开更多
关键词 PHOSPHOLIPIDS INJECTABLE gel leuprolide ACETATE Pharmacokinetics TESTOSTERONE
原文传递
Sexual Function in Men with Castrate Levels of Testosterone: Observations of a Subgroup of Sexually Active Men with Prostate Cancer Undergoing Androgen Deprivation Therapy
7
作者 Evan Ng Tammy Corica +2 位作者 Sandra Turner Adeline Lim Nigel Spry 《Open Journal of Urology》 2014年第7期98-103,共6页
Purpose: To identify possible factors that influence sexual function in men undergoing maximal androgen deprivation therapy (ADT). Patients and Methods: A descriptive exploration was performed looking at characteristi... Purpose: To identify possible factors that influence sexual function in men undergoing maximal androgen deprivation therapy (ADT). Patients and Methods: A descriptive exploration was performed looking at characteristics of twenty-two men reporting sexual activity after nine months of maximal ADT. This previously published Phase II study, involved 250 prostate cancer patients undergoing intermittent ADT. An analysis between this cohort and the group that did not maintain sexual function was performed to ascertain if age, testosterone level, functional status or maintenance of quadriceps strength had an impact upon sexual function. Results: There was no difference in age, testosterone level or ECOG performance status between the sexually active and non-sexually active groups. Over the course of 9 months of ADT, the sexually active group appeared to maintain quadriceps muscle strength as measured with physical stands, and maintained overall health as measured by quality of life questionaries, compared to the non-sexually active group. Conclusions: This retrospective study suggests that exercise during ADT may reduce the impact of ADT on sexual function. This warrants further testing, and could be the focus of future randomised controlled trials. 展开更多
关键词 Prostate Cancer Intermittent ANDROGEN Suppression Exercise Sexual Function leuprolide FLUTAMIDE
下载PDF
Cyst aspiration with gonadotropin suppression in ovarian remnant syndrome with ureteral obstruction: A case report
8
作者 David J. DeWitt Kathleen Eyster Keith A. Hansen 《Open Journal of Obstetrics and Gynecology》 2012年第4期337-339,共3页
Background: Ovarian remnant syndrome (ORS) is characterized by functional ovarian tissue following bilateral salpingo-oophorectomy. ORS presents with pelvic pain or mass, but may also present with urinary tract sympto... Background: Ovarian remnant syndrome (ORS) is characterized by functional ovarian tissue following bilateral salpingo-oophorectomy. ORS presents with pelvic pain or mass, but may also present with urinary tract symptoms resulting from enlarging residual tissue. Case: A 37 year old woman presented with pelvic pain radiating to her flank due to ureteral obstruction from an enlarging ovarian cyst in ORS. Transvaginal ultrasound guided, ovarian cyst aspiration accompanied by leuprolide acetate gonadotropin suppression resulted in acute and chronic relief of ureteral obstruction. Conclusion: This case demonstrated successful treatment of ureteral obstruction caused by an ovarian cyst in a patient with ORS via cyst aspiration and leuprolide acetate gonadotropin suppression. This treatment is a viable alternative for management of ORS, but sacrifices pathologic diagnosis when compared to traditional surgical resection. 展开更多
关键词 OVARIAN REMNANT Syndrome Ureteral Obstruction leuprolide Acetate
下载PDF
长效Eligard剂型获得许可证
9
作者 全伟华 《国外药讯》 2003年第5期30-30,共1页
关键词 Eligard 缓释剂型 前列腺癌 leuprolide
下载PDF
产科和妇科
10
作者 Hugg.,GR 林守清 《美国医学会杂志(中文版)》 1990年第5期297-298,共2页
关键词 产科 妇科 亮脯利得 leuprolide
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部